MoonLake Immunotherapeutics Increase (Decrease) in Other Receivables
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-10
- MoonLake Immunotherapeutics increase (decrease) in other receivables for the quarter ending 2026-06-30 was $798.00K, a 90.00% increase year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for the quarter ending 2026-03-31 was $894.00K, a 512.33% increase year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for the quarter ending 2025-12-31 was $847.00K, a 94.27% increase year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for the quarter ending 2025-09-30 was $612.00K, a 16.16% decline year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for fiscal 2025 was $2.02M, a 13.38% increase from fiscal 2024.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for fiscal 2024 was $1.79M, a 112.62% increase from fiscal 2023.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for fiscal 2023 was $840.00K, a 1128.88% increase from fiscal 2022.
- MoonLake Immunotherapeutics increase (decrease) in other receivables for fiscal 2022 was $68.36K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 9 month as first filed | Increase (Decrease) in Other Receivables 10 month | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.69M 10-Q · filed 2026-08-10 | $2.54M derived: sum of 3 quarters · filed 2026-08-10 | $3.15M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | $894.00K 10-Q · filed 2026-05-11 | $1.74M derived: sum of 2 quarters · filed 2026-05-11 | $2.35M derived: sum of 3 quarters · filed 2026-05-11 | $2.77M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.46M derived: sum of 2 quarters · filed 2026-02-25 | $1.88M derived: sum of 3 quarters · filed 2026-08-10 | $2.02M 10-K · filed 2026-02-25 | |||||
| 2025-09-30 | $612.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.03M derived: sum of 2 quarters · filed 2026-08-10 | $1.18M 10-Q · filed 2025-11-05 | $1.61M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | $420.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $566.00K 10-Q · filed 2026-08-10 | $1.00M derived: sum of 3 quarters · filed 2026-08-10 | $1.73M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | $146.00K 10-Q · filed 2026-05-11 | $582.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.31M derived: sum of 3 quarters · filed 2026-05-11 | $1.49M derived: sum of 4 quarters · filed 2026-05-11 | |||||
| 2024-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.17M derived: sum of 2 quarters · filed 2026-02-25 | $1.35M derived: sum of 3 quarters · filed 2026-02-25 | $1.79M 10-K · filed 2026-02-25 | $1.79M 10-K · filed 2025-02-26 | ||||
| 2024-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $911.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.35M 10-Q · filed 2025-11-05 | $1.35M 10-Q · filed 2024-11-07 | $1.69M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $620.00K 10-Q · filed 2025-08-05 | $619.95K 10-Q · filed 2024-08-07 | $956.37K derived: sum of 3 quarters · filed 2026-02-25 | $1.06M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $439.00K 10-Q · filed 2025-05-12 | $439.01K 10-Q · filed 2024-05-07 | $775.37K derived: sum of 2 quarters · filed 2026-02-25 | $876.36K derived: sum of 3 quarters · filed 2026-02-25 | $1.12M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $336.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $437.36K derived: sum of 2 quarters · filed 2026-02-25 | $678.68K derived: sum of 3 quarters · filed 2026-02-25 | $840.00K 10-K · filed 2026-02-25 | $839.73K 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $100.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $342.31K derived: sum of 2 quarters · filed 2024-11-07 | $503.63K 10-Q · filed 2024-11-07 | $120.22K derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-06-30 | $241.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $402.64K 10-Q · filed 2024-08-07 | $19.23K derived: sum of 3 quarters · filed 2025-02-26 | $62.72K derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-03-31 | $161.32K 10-Q · filed 2024-05-07 | -$222.09K derived: sum of 2 quarters · filed 2025-02-26 | -$178.60K derived: sum of 3 quarters · filed 2025-02-26 | -$203.13K derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2022-12-31 | -$383.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$339.92K derived: sum of 2 quarters · filed 2025-02-26 | -$364.44K derived: sum of 3 quarters · filed 2025-02-26 | $68.36K 10-K · filed 2025-02-26 | |||||
| 2022-09-30 | $43.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $18.96K derived: sum of 2 quarters · filed 2023-11-14 | $451.76K 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$24.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $408.27K 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | $432.80K 10-Q · filed 2023-05-11 | ||||||||
| 2021-12-31 | $148.77K 10-K · filed 2023-03-20 | ||||||||
| 2021-09-30 | $56.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $66.81K 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | $10.78K 10-Q · filed 2022-08-12 |